Measurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer’s Disease and Related Disorders

Behavioral and psychological symptoms (BPSD) are now known to be frequently associated to cognitive and functional decline in Alzheimer‘s disease and related disorders. They are present since the early stages of the disease and have negative impact on the disease process. BPSD assessment is crucial...

Descripción completa

Detalles Bibliográficos
Autores principales: David, Renaud, Mulin, Emmanuel, Mallea, Patrick, Robert, Philippe H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033930/
https://www.ncbi.nlm.nih.gov/pubmed/27713359
http://dx.doi.org/10.3390/ph3082387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033930/
https://www.ncbi.nlm.nih.gov/pubmed/27713359
http://dx.doi.org/10.3390/ph3082387

Ejemplares similares